Investment
Features
FeesSafety
Academy
More
Pluang+

Burford Capital plans $300M senior secured notes offering to refinance 2028 debt.

Company Fundamentals
14 Sep 2026
PRNewsWire
View Source
Neutral
Burford Capital plans $300M senior secured notes offering to refinance 2028 debt.

Burford Capital announced a planned private offering of $300 million in senior secured notes due 2029 through its subsidiary, Burford Capital Global Finance LLC. The proceeds will be used to redeem $400 million of existing 6.25% senior notes due 2028, subject to successful financing and market conditions. The new notes will be secured by the subsidiary's assets and guaranteed by Burford Capital. This refinancing aims to manage Burford's debt maturity profile and potentially improve financing terms. The offering targets qualified institutional buyers and non-US persons, with restrictions on retail investors in the US, EEA, and UK.

Burford Capital's planned private offering of $300 million in senior secured notes provides context for readers. For those following the Financials sector, here is Pluang's market snapshot as of Sep 14, 2026 19:01 WIB: out of 74 priced US Financials stocks, 33 rose and 28 fell. Notable movers include KB Financial Group, Inc. at USD 133.82 (+1.37%), Aon PLC at USD 306.80 (+1.36%), and S&P Global Inc at USD 416.00 (+1.29%).

More News

Grupo Aeroportuario del Pacífico Q3 earnings miss estimates despite revenue and EBITDA growth.

Grupo Aeroportuario del Pacífico Q3 earnings miss estimates despite revenue and EBITDA growth.

Grupo Aeroportuario del Pacífico reported Q3 2026 earnings per share of $2.66 and revenue of $632.9 million, both below analyst expectations. Despite the miss, the company saw a 13.2% rise in revenue excluding construction services and a 19.2% increa...

Company Fundamentals
Neutral
30 minutes ago
Northern Trust Q3 2026 earnings expected to rise on higher interest and fee income.

Northern Trust Q3 2026 earnings expected to rise on higher interest and fee income.

Northern Trust is set to report its Q3 2026 earnings with analysts forecasting a 24.9% rise in earnings per share to $2.86 and an 11.8% increase in revenue to $2.26 billion. Growth is driven by an 11.4% increase in net interest income and a 12.1% ris...

Company Fundamentals
Bullish
33 minutes ago
Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...

Company Fundamentals
Neutral
1 hour ago
Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...

Analyst Insights
Bullish
2 hours ago
Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...

Company Fundamentals
Bearish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App